Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors.
3,225,000 shares of common stock will be purchased at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Expected Gross Proceeds
Approximately $3.9 million before deducting expenses.
Closing Date
Expected to close on August 15, 2025.
Placement Agent
Maxim Group LLC is the sole placement agent.
Registration Statement
Offering made pursuant to an effective shelf registration statement on Form S-3.
- The offering is a step towards financing the development and distribution of novel specialty products.
- The amount raised will support Scienture Holdings, Inc.'s expansion and market presence.
Scienture Holdings, Inc.'s strategic securities purchase agreement signifies a significant milestone in its growth and commitment to enhancing value in the pharmaceutical industry.